Nomura Holdings
AVEO

Nomura Holdings’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Nomura Holdings’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-2,476
Closed -$24K – 1456
2016
Q2 		$24K Buy
+2,476
New +$23.9K ﹤0.01% 1185
2013
Q4 		– Sell
-1,023
Closed -$21K – 2458
2013
Q3 		$21K Sell
1,023
-1,692
-62% -$38.7K ﹤0.01% 2175
2013
Q2 		$68K Buy
+2,715
New +$116K ﹤0.01% 2042

Other funds holding AVEO

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
DVC
Deer VI & Co Larchmont, New York $2.23M AUM 9.32% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Nomura Holdings's AVEO Position: Q3 2016 in Review

Nomura Holdings sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q3 2016, closing a stake of 2,476 shares — an estimated $24K sold.

Nomura Holdings first reported a position in AVEO in Q2 2013 and held it in 3 quarters. The position peaked at $68K in Q2 2013. 44 funds tracked by Wall St. Rank hold AVEO as of Q3 2016.

  • Nomura Holdings reported no remaining AVEO Pharmaceuticals, Inc. position as of Q3 2016 after selling out during the quarter.
  • Nomura Holdings sold 2,476 AVEO Pharmaceuticals, Inc. shares in Q3 2016, an estimated $24K.
  • Nomura Holdings first reported a position in AVEO Pharmaceuticals, Inc. in Q2 2013 and held it in 3 quarters.
  • Nomura Holdings's AVEO Pharmaceuticals, Inc. position peaked at $68K in Q2 2013.
  • 44 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q3 2016.

Based on Nomura Holdings's 13F filing for Q3 2016, filed 14 Nov 2016.